Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Kiniksa Pharmaceuticals Ltd
Operating Income
Kiniksa Pharmaceuticals Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
Operating Income
-$30.5m
|
CAGR 3-Years
44%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Kiniksa Pharmaceuticals Ltd's Operating Income?
Operating Income
-30.5m
USD
Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Operating Income amounts to -30.5m USD.
What is Kiniksa Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
28%
The average annual Operating Income growth rates for Kiniksa Pharmaceuticals Ltd have been 44% over the past three years , 28% over the past five years .